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Synthetic methodology for the generation of novel 1,2,5-oxathiazole-S-oxides from cycloaddition of nitrile oxide 
dipoles with α-oxo sulfines generated in situ via the α-sulfinyl carbenes derived from α-diazosulfoxides is described. 
Experimental evidence and mechanistic rationale for the unanticipated interconversion of the diastereomeric 1,2,5-
oxathiazole-S-oxide cycloadducts are discussed. Notably, using rhodium acetate as a catalyst at 0oC under traditional 
batch conditions led to the selective formation and isolation of the kinetic isomers, while, in contrast, using continuous 




Heterocyclic systems are common motifs in biologically active compounds including pharmaceuticals and natural 
products. 1-4 While 1,4,2-oxthiazoles are commonly reported and described in the literature,5,6 the regioisomeric 1,2,5-
oxathiazole has only rarely been described.7,8 In 1,3-dipolar cycloaddition reactions between nitrile oxide and 
thioketones, the 1,4,2-oxathiazole is formed regioselectively in preference to the 1,2,5-oxathiazole.9 1,4,2-
Oxathiazoles can be envisaged as sulfur analogues of 1,2,4-oxadiazoles which have been found to show anticancer 
activity via inducing apoptosis.9 In addition to the widely reported 1,4,2-oxathiazoles, there are a few reported 































Figure 1  Five membered heterocyclic motifs 
To the best of our knowledge, there are no reported examples of a general synthetic method to access 1,2,5-
oxathiazoles or the corresponding 1,2,5-oxathiazole-S-oxides. There are only two example of 1,2,5-oxathiazole-S-oxide 
in the literature, and in both cases the heterocycle is described as an unexpected product formed from cycloaddition 
of sulfines (Scheme 1), while the opposite regiochemistry is normally preferred.10-12 Interestingly, of the two reported 
1,2,5-oxathiazole-S-oxides in the literature, Zwanenburg has investigated the thermal fragmentation of one 1,2,5-
oxathiazole-S-oxide which was isolated as an unexpected regioisomer from the cycloaddition of fluorinethione-S-oxide 
and benzonitrile oxide.10,11 The thermal fragmentation of 1,4,2-oxathiazoles has been used as a method to access 
isothiocyanates with the rearrangement occurring under mild thermal conditions.13,14  Highlighting the interest in 
these types of compounds, is a recent report by Pierce which focused on the synthesis of 1,4,2-oxathiazoles, through 
oxidative cyclisation of thiohydroximic acids,5 as well as a report by Mloston who generated fluorinated 1,4,2-
































Scheme 1: Synthesis of 1,2,5-oxathiazole-S-oxides. 
Previously our research group has reported the transformation of α-diazosulfoxides to α-oxo sulfines via a hetero-
Wolff rearrangement of the intermediate α-sulfinyl carbene (Scheme 2). This transformation occurs under a range of 
mild reaction conditions including transition metal catalysis, thermolysis, microwave irradiation and photolysis.15-17 
Trapping as Diels-Alder cycloadducts has confirmed the intermediacy of α-oxo sulfines.16,18 While in early work, modest 
yields of α-diazosulfoxides were achieved, we have recently demonstrated that they are more readily accessible 
through use of continuous flow in high yields under mild conditions. Accordingly their use as synthetic precursors to 
highly functionalised heterocyclic scaffolds is now feasible.17-21 Recently, the advantages22-27 of flow chemistry such as 
an enhanced safety profile,20,22 faster scale up,28,29 library synthesis,30 green chemistry,31,32 online analysis33 and self-
optimising reactors34,35 have all been described. These advantages have been utilised across a range of reaction types 















α-diazosulfoxide α-sulfinyl carbene α-oxo sulfine  
Scheme 2: Rearrangement of α-diazosulfoxide to α-sulfine via hetero-Wolff rearrangement. 
While cycloaddition to sulfines and α-oxo sulfines is well established, in many instances the cycloadducts are 
labile and undergo subsequent rearrangement to more stable species.10,42-44 While examples of dipolar cycloadditions 
have been described in continuous flow,45-47 herein we describe dipolar cycloaddition of α-oxo sulfines derived from 
α-diazosulfoxides48 under mild reaction conditions with nitrile oxides to form oxathiazole-S-oxides is described. Most 
interestingly, the stereochemical outcome of the transformations can be directed by alteration of the reaction 
conditions.   
 
Results and Discussion 
While the original synthesis of α-diazosulfoxides was reported 20 years ago, their synthetic utility was limited by poor 
yields and difficulty in accessing synthetically useful quantities of these liable compounds. Recently we have 
demonstrated that improved yields and efficiencies can be obtained through use of continuous flow reaction 
conditions for the diazo transfer step, which overcame the sensitivity of the products to basic reaction conditions by 
removing the product from the immobilised base as it formed (Scheme 3).19,48  
For this study of dipolar cycloadditions with nitrile oxides, sulfines generated from the ketone derived alpha-
































































Scheme 3: Range of α-diazosulfoxides synthesised in flow or batch  
While nitrile oxide dipoles are usually generated in situ by base mediated dehydrohalogenation of the imidoyl chloride, 
these conditions would not be compatible with base labile α-diazosulfoxides19 and their transformation to α-oxo 
sulfines. Nitrile oxides 12–16 were selected for investigation to enable exploration of electronic effects and steric 
effects of substituted aryl rings. While a few isolated examples of the generation of nitrile oxide dipoles in the absence 
of base have been recently described, in this event our previously reported strategy for pre-generation of the dipole 
proved successful.49 
 
 Cycloadditions of nitrile oxide dipoles with ketone derived α-oxo sulfines. 
 
The α-diazosulfoxides 1, 2, and 4  were synthesised according to the work described earlier and, for each of these 
carbene precursors, the hetero-Wolff rearrangement was initiated under a range of different conditions, resulting in 
the corresponding α-oxo sulfines 17, 18, and 19 (Scheme 4).19,18,48 Initial investigations focused on the hetero-Wolff 
rearrangement of the α-diazosulfoxide 1 to form the α-oxo sulfine 17 via the α-sulfinyl carbene intermediate, and  
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Scheme 4 
Reaction of the α-oxo sulfine 17, generated from α-diazosulfoxide 1 under rhodium acetate catalysis, with p-
nitrobenzonitrile oxide 14 as an in situ trap, in batch reaction conditions was undertaken using the freshly re-generated 
nitrile oxide dipole to avoid unnecessary exposure of the α-diazosulfoxide 1 to basic conditions. Following stirring for 
1h 1H NMR spectroscopy indicated complete consumption of both the α-diazosulfoxide 1 and intermediate α-oxo 
sulfine 17. On concentration, 1H NMR spectroscopy of the crude product indicated a mixture of regioisomers (1,2,5-
oxathiazole-S-oxides and 1,4,2-oxathiazole-S-oxides) and diastereomers. These components were later identified (see 
below) as the kinetic 1,2,5-oxathiazole-S-oxide 20, the thermodynamic 1,2,5-oxathiazole-S-oxide 21, a 1,4,2-
oxathiazole-S-oxide regioisomer 22 and a 1,4,2-oxathiazole reduction product 23, in the ratio of 40 : 29 : 22 : 9. No 
evidence was observed for a second diastereomer of the 1,4,2-oxathiazole-S-oxide regioisomer 24.  
Chromatographic purification of the crude reaction mixture led to the isolation of two pure cycloadducts: the kinetic 
diastereomer 20 and the 1,4,2-oxathiazole 23, both of which had been observed in the 1H NMR spectrum of the crude 
product mixture, while the thermodynamic isomer 21 was not isolated as a pure compound.  The structure of the 
reduction product 23 was assigned by comparison to spectroscopic data reported for similar 1,4,2-oxathiazoles5,9 and 



















































Scheme 5: Initial investigation in to the cycloaddition reaction 
Determination of the regio- and stereochemistry of the cycloadducts proved interesting. When a pure sample (by 1H 
NMR) of the major cycloadduct 20 was recrystallised from dichloromethane/toluene, X-ray crystallography revealed 
the structure as the 1,2,5-oxathiazole-S-oxide illustrated in Figure 2. Following crystal structure determination, the 
single crystal used was recovered from the crystallographic pin and re-analysed by 1H NMR spectroscopy (600 MHz) 
to unambiguously confirm the relative stereochemistry. Unexpectedly it was clear that the compound present was no 
longer 20, but had rearranged to compound 21 isolated following recrystallisation. Following this unanticipated 
observation, the conversion of the initially isolated kinetic diastereomer to the more stable thermodynamic 







Figure 2: Relative stereochemistry of the 1,2,5-oxathiazole-S-oxide 21. 
This interesting observation suggested interconversion between a kinetic isomer 20 which was originally isolated and 
the thermodynamic isomer 21. Analysis of the remaining solid sample that the crystal was taken from, showed 
approximately a 1:1 ratio of the diastereomers 20 and 21. Thus it appears, the kinetic cycloadduct 20, formed by 
cycloaddition of the nitrile oxide dipole, to the kinetically favoured Z-sulfine, interconverts to the isomer 21 over time. 
Subsequent direct observation of this interconversion by 1H NMR spectroscopy is included in the ESI. Previously, low 
yields of cycloadducts from dipolar additions of sulfines had been rationalised by the ability to easily undergo 
cycloreversion reaction.22,50-54 However, transformation of a kinetic diastereomer to a more stable thermodynamic 
diastereomer was an unexpected property of these heterocyclic compounds. Zwanenburg et al.52 have described 1,3-
dipolar cycloaddition of sulfines with diphenylnitrilimine to lead to a 1:1 mixture of 1,3,4-thiadiazoline-S-oxides which 
lose their stereochemical integrity over time due to interconversion through a ring opened intermediate.52 
While formation of the major kinetic diastereomer 20 is envisaged from cycloaddition of the nitrile oxide to the Z 
sulfine as illustrated in Scheme 6, notably, the formation of the cycloadduct 21 can be envisaged by two pathways: 
either by interconversion of the kinetic isomer 20, as directly evidenced by crystallographic and spectroscopic studies, 
or potentially through cycloaddition to the E α-oxo sulfine, which cannot be ruled out as a competing cycloaddition 
pathway. The interconversion of the kinetic cycloadduct 20 to the thermodynamic isomer 21 can be rationalised via a 
zwittterionic intermediate as illustrated in Scheme 6. From the crystal structure of the thermodynamic isomer 21 
(Figure 2), it is clear that the two electron rich oxygen atoms are pointing away from each other. In the kinetic isomer 
20, due to the opposite stereochemistry at the spiro centre, repulsion between the two oxygen atoms would be 
anticipated, providing a driving force for the rearrangement from the kinetic isomer  20, to the thermodynamic isomer 








































Alternatively the interconversion of the kinetic isomer 20 and the thermodynamic isomer 21 can be rationalised via a 
cycloreversion reaction to re-form the α-oxo sulfine and nitrile oxide, which subsequently undergo a cycloaddition to 
form the thermodynamically favoured isomer 21. There is no experimental evidence to support this pathway. 
 To confirm that this rearrangement occurred consistently across the series of compounds, the interconversion from 
the kinetic isomer to the thermodynamic isomer was monitored over time by 1H NMR spectroscopy, for a number of 
cycloadducts (20 to 21, 32 to 31, 35 to 34), and the data are presented in the ESI.  
Optimisation of reaction conditions to form cycloadducts 
A series of reaction conditions were investigated to establish the optimum conditions for the preferential formation 
of the thermodynamic isomer of the 1,2,5-oxathiazole-S-oxide products which proved to involve thermolysis (10 
minutes) in continuous flow (Table 1, entry 7). The investigation began with batch conditions, inducing the hetero-
Wolff rearrangement using transition metal catalysis (Table 1, entries 1-3), or thermolysis. Use of microwave 
irradiation also successfully promoted the cycloaddition reaction with desired product isolated in 18 % yield following 
chromatography. With long reaction times required in batch for preferential generation of the thermodynamic isomer, 
and the limitations on scale in microwave reactions, continuous flow conditions were next investigated (Table 1). α-
Oxo sulfine generation via transition metal catalysis or thermolysis were explored in continuous flow, with a much 
cleaner transformation occurring in the absence of the catalyst rhodium acetate. Thermolysis reactions in continuous 
flow have recently been used for the generation of various reactive intermediates including ketenes and nitrenes.55-57 
Based on a report in the literature that a neutral alumina bed can be used for the removal of excess nitrile oxide and 
furoxan dimers, in a continuous flow process, this was utilised in this work (Table 1, entry 7).58 Furthermore, inclusion 
of an alumina column in line prevents further reactions occurring in the collection flask by removal of unreacted dipole 
from the reaction outflow. The crude material from this entry was then recrystallized from ether and hexane to give 
the pure cycloadduct  21 in 52% yield.  
 










































































K : T : A : B : C 
20 : 21 : 24 : 22 : 23 
(yield) 
1 Batch at r.t. 
(EtOAc/DCM, 1:1) 
Rh2(OAc)4 
(5 mol %) 
60  2.3 40 : 29 : 0 : 22 : 9 
24% : 0 : 0 : 0 : 15% 
2 Batch  
(CH3CN/DCM, 1:1) 
Rh2(OAc)4 




4 1 : 1.2 : 0 : 0 : 0 : 5.3(26) 
1 : 3.3 : 0 : 0 : 0 : 11.3(26)f 
0 : 25% : 0 : 0 : 0 : 42%f 
3 Batch at r.t. 
(EtOAc/DCM, 1:1) 
Rh2(OAc)4 
(5 mol %) 
90  4 4 : 3 : 0 : trace : 0 
0 : 17% : 0 : 0 : 0  
4 Microwave (100°C) 
(DCM) 
MW 10 2.5 9 : 81 : 0 : 9 : 0 
0 : 18% : 0 : 0 : 0  
5 Flowb (100°C) 
(DCM) 
Thermolysisa 10 4 25 : 50 : 0 : 0 : 0f 
6 Batch (-20°C)d  
(Et2O) 
Rh2(OAc)4 
(5 mol %) 
180 1 Complex Mixturee 
7 Flowb,c (100°C) 
(EtOAc/DCM, 1:1) 
Thermolysisa 10 2 10 : 56 : 0 : 14 : 0 
0 : 52% : 0 : 0 : 0 
8 Flowb,c (100°C) 
(EtOAc/DCM, 1:1) 
Thermolysisa 30  2 10 : 83 : 0 : 7 : 0e 
9 Flowb,c (100°C) 
(EtOAc/DCM, 1:1) 
Thermolysisa 10  4 17 : 72 : 0 : 11 :0e 
10 Flowb,c (r.t.) 
(EtOAc/DCM, 1:1) 
Rh2(OAc)4 
(5 mol %) 
60 2 52 : 38 : 0 : 10 : 0e  
11 Batch (r.t.) 
(EtOAc/DCM, 1:1) 
Rh2(OAc)4 
(5 mol %) 
30 2                 57 : 43 : 0 : 18 : 0e 
12 Batch  (0°C) 
(EtOAc/DCM, 1:1) 
Rh2(OAc)4 
(5 mol %) 
30 2                58 : 29 : 0 : 3 : 10e 
aThermolysis reactions were carried out at 100°C in continuous flow. 
bAll continuous flow reaction were carried out with an 8 bar back pressure regulator fitted to the system. 
cA packed bed of alumina was used in a 10 mm id Omnifit® glass column. 
d Carried out at -20°C.59 
eThe crude reaction mixture was not purified 
f The major product was the oxadiazole from the cycloaddition of the nitrile oxide dipole and the solvent, acetonitrile.  
g The ratio of product in the crude material was determined by integration of the CH2 signals alpha to the spiro centre. 
* Flow reactions conducted using a Vapourtec E-Series reactor (Vapourtec V3 peristaltic pumps), solution was pumped through a 10 mL reaction 
coil (Vapourtec part number 50-1011) heated to 100°C at a rate of 1 mL/min giving a residence time of 10 min, followed by a 10 mm id Omnifit™ 
glass column (Vapourtec part number 30-3296) packed with Alumina (volume ~ 1 mL). PFA tubing was used throughout the system. The reaction 
mixture passed through a fixed 7 bar back pressure regulator (Kinesis part no. P-787), the crude material was collected as an orange solution 
and concentrated under reduced pressure. 
  
From this investigation of the impact of variation of the reaction conditions, it is clear that carrying out the reaction 
using the rhodium acetate catalyst, in batch reaction conditions, at 0°C to room temperature favours the selective 
formation of the kinetic isomer, which can be isolated and fully characterised before interconversion. Thus, reaction 
conditions were established for the preferential formation of either of the two diastereomeric products which were 
subsequently applied to a range of substrates.  
Isolation of kinetic 1,2,5-oxathiazole-S-oxides 
With reaction conditions established for the preferential formation and isolation of the kinetic Isomer 20 in pure form, 
generation and isolation of a series of kinetic 1,2,5-oxathiazole-S-oxides using a range of nitrile oxide dipoles, 12–16 
was undertaken in order to confirm that the unanticipated conversion to the more stable thermodynamic isomer is 
consistent across the series. The kinetic isomers were generated in batch reaction conditions, at 0°C with 2 equivalents 
of the dipole in each case. Each of the nitrile oxide dipoles 12–16 were pre-generated as a solution in dichloromethane 
and added to the corresponding  α-diazosulfoxide. This was followed directly by addition of rhodium acetate dimer to 
promote the hetero-Wolff rearrangement of the α-sulfinyl carbene, to form the reactive α-oxo sulfine 17 in situ which 
is efficiently trapped with each of the nitrile oxides 12–16.  










































1 Ratio 8 47 34  11 
 




28 6%   29 6% 30 9% 
2 Ratio 14 68 7  0 
 
R1 = 4-F(13) 
 
31 32 28% 11% 33  - 





34 35 16% 36  - 





21 20 24% 22 23 15% 





37 38 - 25 8% 
 
In Table 2, Entries 1-4 the targeted kinetic isomers were successfully isolated in each case, albeit in poor yields. 
Although the thermodynamic isomers were present in the 1H NMR spectra of the crude product mixture, in this study 
the thermodynamic isomer was not isolated after purification in most instances. Significantly, while the selectivity for 
the kinetic isomer 20 over 21 was relatively modest, across the series of nitrile oxides formation of the kinetic 
cycloadducts 28, 32 and 35 had a much higher selectivity. This may be due to slower interconversion of the 
cycloadducts and/or more efficient trapping of the Z sulfine with the nitrile oxides. Interestingly, the 1,4,2-oxathiazole-
S-oxide regioisomers were present in four out of the five reactions in Table 3, whereas 1,4,2-oxathiazole was present 
in three of the five reactions. In the case of Table 2, entry 5, only the 1,4,2-oxathiazole 25 was isolated after repeated 
chromatography, in 8% yield. This 1,4,2-oxathiazole 25, whose structure was confirmed by single crystal XRD, is a 
reduction product; the deoxygenation of the sulfoxide may be effected by the rhodium catalyst or the intermediate 
carbene.60 This set of reactions confirm that preferential formation of the kinetic isomer of 1,2,5-oxathiazole-S-oxides 
can be achieved using rhodium acetate dimer (5 mol %) at 0°C, and subsequently isolated and characterised as a pure 
compound in most cases (20, 28, 32, and 35). On storage of each of these isomers, spontaneous interconversion to 
the thermodynamic isomers was observed over time (see below). 
Isolation of Thermodynamic 1,2,5-oxathiazole-S-oxides.  
With the optimum conditions in hand for the synthesis of the thermodynamically preferred stable cycloadducts (i.e. 
thermolysis in flow, Table 1, entry 8), the α-diazosulfoxides 1, 2 and 4 and substituted aryl nitrile oxide dipoles 12–16 
were combined to generate a novel series of 1,2,5-oxathiazole-S-oxide cycloadducts in moderate yields (Table 3 ). 
In each case, the thermodynamic 1,2,5-oxathiazole-S-oxide was the principal product formed and isolated as a pure 
component following chromatography. As summarised in Table 3, smaller amounts of the other cycloadducts were 
seen in the crude product mixtures including the kinetic 1,2,5-oxathiazole-S-oxide, the 1,4,2-oxathiazole-S-oxide 
regioisomers, and in some instances samples of these were isolated. Notably 1,4,2-oxathiazole was not formed under 
these conditions in any instance, indicating that the sulfoxide reduction only occurs in the presence of the rhodium 
catalyst.  
In all cases, as with the earlier reactions, the dipole was freshly generated each time and added as a solution in 
dichloromethane, to the α-diazosulfoxide and the mixture subjected to thermolysis under continuous flow. Under 
these conditions efficient transformation of the α-diazosulfoxide to the α-oxo sulfine is achieved. Trapping of the Z α-
oxo sulfine to form the kinetic 1,2,5-oxathiazole-S-oxide and the E α-oxo sulfine to form the thermodynamic 1,2,5-
oxathiazole-S-oxide cycloadduct can be envisaged, with subsequent transformation of the kinetic isomer to the 
thermodynamic isomer effected at 100°C.  
Unambiguous confirmation of the regiochemistry and stereochemistry of a number of the thermodynamic 1,2,5-
oxathiazole-S-oxides was undertaken by single crystal XRD (Figure 3). 
Interestingly while across the series of compounds there is evidence that the kinetic 1,2,5-oxathiazole-S-oxide 
cycloadducts convert to the thermodynamic isomers, the rate of the interconversion varies depending on the 
substituents. In particular, 1H NMR spectroscopy on a sample of the kinetic t-butyl derivative 35 following storage for 
6 months as a solid showed that only a small amount had converted to the thermodynamic isomer 34, while the 
analogous 4-fluoro derivative 32 converted to 31 to a much great extent following 5 months storage (see ESI for 
spectra). The entropic barrier to reorganisation of the sterically demanding t-butyl group in the solid state is evident.  
Undertaking the cycloadditions in continuous flow offers many benefits leading to the thermodynamic 1,2,5-
oxathiazole-S-oxides in a metal free and catalyst free transformation. In addition, the benefits of continuous flow 
processing result in an easily controlled thermolysis (rapid heating, excellent thermal transfer and efficient removal of 
the product from the hot zone once formed) and a readily scalable process.  
  




































1 Ratio: 63 12 7,15 
 
 R1 = H, R2 = H 27 32% 28 39 , 29 
2 Ratio 78 12 10 
 R1 = 4-tBu,  
R2 = H 
34 30% 35  40 5% 
3 Ratio 63 18 12 
 R1 = 4-F, R2 = H 31 35% 32 12% 33 4% 
4 Ratio 





14   
 22  
5 Ratio 





9   
41  
6 Ratio 
R1 = H, R2 = 2-Me 
78 




 44  
7 Ratio 
R1 = 4-F, R2 = 2-Me 
77 






R1 = 4-tBu, R2 = 2-
Me 
78 






R1 = 4-NO2 R2 = 2-
Me 
85 




  53  
10 Ratio 
R1 = H, R2 = 4-Me 
64 




 56 11% 
11 Ratio 
R1 = 4-F, R2 = 4-Me 
73 
  57 36% 
14 
  58 5% 
13 
 59 10% 
12 Ratio 
R1 = 4-tBu, R2 = 4-
Me 
80 






R1 = 4-NO2, R2 = 4-
Me 
77 
 62 45% 
17 
 63 11% 
6 
 64  
14 Ratio 
R1 = 2,5-DiF, R2 = 4-
Me 
53 







*Yields of pure compounds isolated after column chromatography on silica gel are given in the table. There was no notable change in the efficiency of the 




































Figure 3: Confirmation of regiochemistry and stereochemistry for a range of thermodynamic 1,2,5-oxathiazole-S-oxides. Structures are 
displayed using the Mercury 2.7 package.  
 
  
Exploiting the differences between use of a rhodium catalyst or thermolysis in flow, two sets of reaction conditions 
have been established to predictably lead to preferential formation of either the kinetic isomer or the thermodynamic 
isomer of a 1,2,5-oxathiazole-S-oxide cycloadducts through trapping of α-oxo sulfines with nitrile oxides. Most reports 
of nitrile oxide cycloadditions with sulfines, are to isolated sulfines, and yield the 1,4,2-oxathiazole-S-oxide 
regioisomer;10 we are not aware of a nitrile oxide cycloaddition to an α-oxo sulfine. It is well established that the 
conjugation in an α-oxo sulfine alters the electronic properties and accordingly the reactivity of the sulfine moiety. In 
Zwanenburg’s discussion of the regioselectivity of cycloaddition of α-oxo sulfines with Danishefsky’s diene, the impact 
of the conjugation to the ketone on the orbital coefficients is highlighted. Thus in an isolated sulfine the largest atomic 
coefficient in the LUMO is on the carbon, while in the oxo-sulfine the polarisation is reversed with the largest 
coefficient now at sulfur.61 The regiochemical outcome of the dipolar cycloadditions in this work can be similarly 
rationalised.  
The key spectroscopic characteristics are consistent across the series of the compounds isolated. The majority of the 
thermodynamic isomers of the 1,2,5-oxathiazole-S-oxides are crystalline solids and the 13C NMR shift of the carbon at 
the spiro centre is extremely consistent across the series, at 96.5 - 97.8 ppm, compared to 92.5 - 93.4 ppm for the 
kinetic 1,2,5-oxathiazole-S-oxide isomers. Furthermore, in each of the diastereomers the AB signals for the 
diastereotopic CH2 are very distinctive in the 1H NMR spectra, and are very consistent across the series. The formation 
of the 1,4,2-oxathiazole-S-oxide regioisomers, is evidenced by the signal for the spiro carbons at ca. 108 ppm in one 
regioisomer  and ca. 110 ppm for the second regioisomer, deshielded relative to the corresponding signal in the 1,2,5-
oxathiazole-S-oxides, due to proximity to oxygen.  For the isolated examples of the 1,4,2-oxathiazoles, the shift of the 
spiro centre is consistently observed between a narrow range of 101.1 – 102.2 ppm in the 13C NMR spectrum. Again, 
a crystal structure of the compound 25 was obtained during this work, unambiguously confirming the heterocyclic 
structure.   
Overall, starting from α-diazosulfoxides, via α-sulfinyl carbene and α-oxo sulfine intermediates, we have generated a 
novel series of fourteen thermodynamic diastereomers and four kinetic diastereomers of 1,4,2-oxathiazole-S-oxide  
cycloadducts, with regiochemistry and stereochemistry confirmed in four cases by single crystal X-ray diffraction 


































In summary, we have successfully established synthetic methodology for the generation of novel 1,2,5-oxathiazole-S-
oxide cycloadducts, an interesting series of spirocyclic heterocycles, from cycloaddition of nitrile oxide dipoles with α-
oxo sulfines generated in situ from α-diazosulfoxides. Through a reaction optimisation study, conditions for the 
isolation of the kinetic isomer were established using rhodium acetate as a catalyst at 0oC under traditional batch 
conditions, while using continuous flow thermolysis optimal conditions for the synthesis of the thermodynamic 
isomers were established. Based on biological activity seen in related heterocycles,62-64  investigation of the biological 
activity of these novel heterocycles is underway and will be reported in due course.  
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Experimental  
 
Representative procedure for reaction conditions for synthesis of the kinetic 1,2,5-oxathiazole-S-oxide as 
major product 
The nitrile oxide dipole 12 was generated from the imidoyl chloride precursor (0.155 g, 1.00 mmol, 2.3 eq) as described in the ESI. The solution 
of dipole 12 was concentrated under reduced pressure and added to the α-diazosulfoxide 1 (0.090 g, 0.43 mmol, 1 eq) in dichloromethane/ethyl 
acetate  (1 : 1, 15 mL). This was followed by the addition of rhodium acetate dimer (0.009 g, 0.02 mmol, 5 mol %). The reaction mixture was 
stirred at room temperature under a nitrogen atmosphere for 1 h. The crude reaction mixture was concentrated under reduced pressure to give 
the crude material as an orange oil. Analysis of the crude material by 1H NMR spectroscopy showed no signals corresponding to either the α-
diazosulfoxide 1, or the intermediate α-oxo sulfine 17. Purification of the reaction mixture by flash chromatography on silica gel using gradient 
hexane-ethyl acetate as eluent (100 : 0 – 60 : 40) led to the elution of multiple fractions. The first fraction to elute was the 1,4,2-oxathiazole 30 
as a yellow crystalline solid (0.026 g, 9%); mp 89 – 90°C; νmax/cm-1 (neat) 1719, 1273, 1083, 743; δH (400 MHz, CDCl3);  3.79 (1H, d, J 18.0, A of 
ABq, one of CH2), 3.92 (1H, d, J 18.0, B of ABq, one of CH2), 7.40 – 7.52 (6H, m, 6 x Aromatic CH), 7.68 – 7.73 (2H, m, 2 x Aromatic CH), 7.89 (1H, 
d, J 7.6, 1 x Aromatic CH);  δC (CDCl3, 100 MHz); 42.7 (CH2, ArCH2), 101.1 (Cq, Cspiro), 125.8, 126.4 (CH, 2 x Aromatic CH), 127.5 (Cq, 1 x Aromatic 
Cq), 128.2 (CH, 2 x Aromatic CH), 128.7 (CH, 2 x Aromatic CH), 131.3 (CH, 1 x Aromatic CH), 132.6 (Cq, 1 x Aromatic Cq), 136.7 (CH, 1 x Aromatic 
CH), 149.2 (Cq, 1 x Aromatic Cq), 155.2 (Cq, C=N), 196.2 (Cq, C=O).  
The second fraction was a mixture of thermodynamic isomer 27 and regiosiomer 29, regio : thermodynamic, 0.73 : 1, 29  : 27. The material was 
characterised as a mixture and spectral characteristics for the 1,4,2-oxathiazole-S-oxide Regioisomer 29 are; (0.023 g, 8%); νmax/cm-1 (neat) 1714, 
1367, 1154; δH (400 MHz, CDCl3); 3.66 (1H, d, J 18.9, A of ABq, one of CH2), 4.28 (1H, d, J 18.4, B of ABq, one of CH2), 7.29 – 7.98 [multiple 
overlapping signals including (3H, m, 3 x ArH), (3H, m, 3 x Aromatic CH), (1H, m, 1 x Aromatic CH), (1H, m, 1 x Aromatic CH) and (1H, m, 1 x 
Aromatic CH)]; δC (CDCl3, 100 MHz); 28.6 (CH2, ArCH2), 110.8 (Cq, Cspiro), 125.6 (Cq, Aromatic Cq), 125.7, 126.8 (CH, 2 x Aromatic CH), 127.6 (1 x 
Aromatic Cq), 128.7 (2 x Aromatic CH), 128.8 (1 x Aromatic CH), 129.5 (CH, 2 x Aromatic CH), 133.0 (Cq, Aromatic Cq), 137.1 (CH, Aromatic CH), 
149.0 (Cq, Aromatic Cq), 158.7 (Cq, C=N), 193.2 (Cq, C=O); (M+H) 298 (30%);  HRMS (ESI+) Exact mass calculated for C16H11NO3S [M-H]+, 298.0538. 
Found: 298.0533. Signals corresponding to 27 are δH (400 MHz, CDCl3) 3.49 (1H, d, J 19.2, A of ABq, CH2), 4.07 (1H, d, J 19.2, B of ABq, CH2), 7.29 
– 7.60 (7H, m, 7 x Aromatic CH), 7.79 (1H, t, J 8.5, 1 x Aromatic CH), 7.96  (1H, d, J 7.8, 1 x Aromatic CH); δC (CDCl3, 100 MHz); 28.9 (CH2, ArCH2), 
97.4 (Cq, Cspiro), 125.6 (Cq, Aromatic Cq), 126.1, 127.0 (2 x CH, 2 x Aromatic CH), 128.0 (CH, 2 x Aromatic CH), 129.2, (CH, 1 x Aromatic CH), 129.4 
(CH, 2 x Aromatic CH), 131.7 (CH, 1 x Aromatic CH), 134.3 (Cq, 1 x Aromatic Cq), 137.1 (CH, 1 x Aromatic CH), 151.6 (Cq, Aromatic Cq), 158.0 (Cq, 
C=N), 192.6 (Cq, C=O). 
The third fraction contained the kinetic diastereomer 28 (0.014 g 6%). νmax/cm-1 (neat)  1716, 1601, 1168, 760;  δH (400 MHz, CDCl3); 3.64 (1H, 
d, A of ABq J 18.8, one of CH2), 3.83 (1H, d, B of ABq, J 18.2, one of CH2), 7.34 – 8.10 [overlapping signals including (2H, t, J  7.6, 8.1, 2 x ArH), a 
(3H, m, 3 x Aromatic CH), a (2H, m, 2 x Aromatic CH), a (1H, t, J 7.3, 8.5, 1 x Aromatic CH) and (1H, d, J 7.8 1 x Aromatic CH).  
4'-(4-(tert-Butyl)phenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide  35 
Kinetic cycloadduct 35 was isolated as a white crystalline solid (0.040 g, 16%). Mp 128 – 129 °C;  νmax/cm-1 (neat) 753, 1165, 1712; δH (400 MHz, 
CDCl3); 1.24 (9H, s, 3 x CH3), 3.62 (1H, d, J 18.4, A of ABq, one of ArCH2), 3.81 (1H, d, J 18.4, B of ABq, one of ArCH2), 7.35 – 7.44 (4H, symmetrical 
q, J  8.7, 4 x Aromatic CH), 7.56 – 7.64 (2H, m, 2 x Aromatic CH), 7.80 (1H, t, J 7.5, 2 x Aromatic CH), 7.96 (1H, d, J 7.8, 1 x Aromatic CH);  δC (CDCl3, 
100 MHz); 31.0 [CH3, C(CH3)3], 32.0 (CH2, ArCH2), 35.0 [Cq, C(CH3)3], 93.4 (Cq, Cspiro), 122.3 (Cq, CqCH2), 125.6 (CH, 1 x Aromatic CH), 126.3 (CH, 2 
x Aromatic CH), 127.1 (CH, 1 x Aromatic CH), 128.0 (CH, 2 x Aromatic CH), 129.3 (CH, 1 x Aromatic CH), 136.6 (Cq, Aromatic Cq), 136.8 (CH, 
Aromatic CH), 149.2 (Cq, Aromatic Cq), 155.6 (Cq, Aromatic Cq-C(CH3)3), 158.8 (Cq, C=N), 191.0 (Cq, C=O); (M+H) 354 (10%); HRMS (ESI+) Exact 
mass calculated for C20H20NO3S [M-H]+, 354.1164. Found: 354.1157. 
4'-(4-Fluorophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide  32 
The first fraction contained the kinetic 1,2,5-oxathiazole-S-oxide 32 (0.045 g, 28%) Yellow oily residue; Found C, 60.54; H 3.40 N 4.30. C16H10NFO3S 
requires C, 60.95; H 3.20 ; N 4.44;  νmax/cm-1 (neat) 1716, 1602, 1508, 1160; δH (400 MHz, CDCl3) 3.60 (1H, d, A of ABq J 18.3, one of ArCH2), 3.83 
(1H, d, B of ABq, J 18.3, one of ArCH2), 7.04 (2H, t, J 8.6, 2 x Aromatic CH), 7.46 – 7.49 (2H, m, 2 x Aromatic CH), 7.58 – 7.65 (2H, m, 2 x Aromatic 
CH), 7.82 (1H, t, J 7.4, 1 x Aromatic CH), 7.96 (1H, d, J 7.7, 1 x Aromatic CH);  δC (CDCl3, 100 MHz); 31.8 (CH2, ArCH2), 93.2 (Cq, Cspiro), 116.7 (CH, 2 
x Aromatic CH, d, 2JCF  22.3),  121.6 (Cq, d, 4JCF 3.5, 1 x Aromatic Cq), 125.7, 127.2, 129.5 (CH, 3 x Aromatic CH), 130.4 (CH, 2 x ArCH, d, 3JCF 9) 
,136.4 (Cq, 1 x Aromatic Cq), 137.0 (CH, 1 x Aromatic CH), 149.0 (Cq, 1 x Aromatic Cq), 158.0 (Cq, C=N), 164.7 (CF, Aromatic CF, d, 1JCF 254.6), 
190.8 (Cq, C=O).The second fraction to elute contained the 1,4,2-oxathiazole-S-oxide Regioisomer 33 (0.018 g, 11%) Pale yellow crystalline solid; 
mp 159 - 161°C; νmax/cm-1 (neat) 1721, 1073, 844; δH (400 MHz, CDCl3) 3.33 (1H, d, J 17.2, A of ABq, one of ArCH2), 3.51 (1H, d, J 17.2, B of ABq, 
one of ArCH2), 7.18 – 7.24 (3H, m, 3 x Aromatic CH), 7.51 – 7.58 (2H, m, 2 x Aromatic CH), 7.77 (1H, t, J 8.7, 2 x Aromatic CH), 7.93 – 7.98 (2H, m, 
2 x Aromatic CH); δC (CDCl3, 100 MHz) 33.6 (CH2, ArCH2), 108.3 (Cq, Cspiro), 117.0 (CH, 2 x Aromatic CH, d, 2JCF  22), 125.6, 127.1, 129.4 (CH, 3 x 
Aromatic CH), 131.0 (CH, 2 x ArCH, d, 2JCF 9), 135.2 (Cq, 1 x Aromatic Cq), 137.1 (CH, 1 x Aromatic CH), 147.4 (Cq, 1 x Aromatic Cq), 158.4 (Cq, 
C=N), 188.9 (Cq, C=O).The CF bond was not observed in the 13C NMR spectrum.  
4'-(2,5-Difluorophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one  25  
Only 1,4,2-oxathiazole 25 was isolated, as a pale yellow crystalline solid (0.018 g, 8%). mp 89 – 91°C; νmax/cm-1 (neat) 1726, 1483, 1272; δH (400 
MHz, CDCl3) 3.78  (1H, d, J 18.0, A of ABq, one of ArCH2), 3.91 (1H, d, J 18.0, B of ABq, one of ArCH2), 7.10 – 7.19 (2H, m, 2 x Aromatic CH), 7.46 – 
7.50 (2H, m, 2 x Aromatic CH), 7.57 – 7.61 (1H, m, 1 x Aromatic CH), 7.72 (1H, t, J 8.5, 1 x Aromatic CH), 7.88 (1H, d, J 7.6, 1 x Aromatic CH); δC 
(CDCl3, 100 MHz) 42.5 (CH2, ArCH2), 101.1 (Cq, Cspiro), 115.8 (CH dd, 2JCF 26.0, 3JCF 3.0, 1 x Aromatic CH), 117.0 (Cq, dd,  2JCF 14.6, 3JCF 9.0, 1 x 
Aromatic Cq), 117.7 (CH, dd, 2JCF 25.5, 3JCF 8.7, 1 x Aromatic CH), 119.5 (CH, dd, 2JCF  25.5, 3JCF 8.8, 1 x Aromatic CH), 125.9. 126.4, 128.9 (CH, 3 x 
Aromatic CH), 132.4 (Cq, 1 x Aromatic Cq), 136.8 (CH, 1 x Aromatic CH), 148.8 (Cq, 1 x Aromatic Cq), 149.3 (Cq, C=N), 155.8 (Cq, 1 x Aromatic CF, 
d, 1JCF 251), 158.3 (Cq, 1 x Aromatic CF, d, 1JCF 245), 196.0 (Cq, C=O); m/z (ESI+) 334 [M+H]+ (25%); HRMS (ESI+) Exact mass calculated for 
C16H10NO3F2S [M+H]+, 334.0349 Found: 334.0345. The relative stereochemistry of the cycloadduct 25 was determined by single crystal X-ray 
diffraction on a crystalline sample of 25 recrystallized from dichloromethane/hexane. Crystals of 25 are monoclinic, space group P 21/c. Crystal 
data for C16H9F2NO2S, Mr = 317.30, a =  14.0083 (10) Å, b = 8.7108 (6) Å, c = 11.54178 (8) Å, α = γ = 90 °C, β = 105.733 (2)°, V = 1355.62 (16) Å3, Z 
= 4, Dc = 1.555 g cm-3, F000 = 648, Cu Kα radiation, λ = 1.541 Å, T = 296 K, 2θmax = 0.753°, μ = 2.417 mm-1,15370 reflections collected, 2344 unique 
(Rint = 0.0332), final GooF = 1.100, R1 = 0.0328, wR2 = 0.0920 (2299 obs. data: I > 2σ(I)); R1 = 0.0335, wR2 =  0.0927 (all data).  
(2R,2'R)-4'-(4-nitrophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide 20 
The first fraction to elute was the 1,4,2-oxathiazole 23 (0.031 g, 15%);  mp 175 – 177°C; νmax/cm-1 (neat) 1715, 1597, 1518; δH  (400 MHz, CDCl3)  
3.82 (1H, d, J 17.9, A of ABq, one of ArCH2), 3.95 (1H, d, J 17.9, B of ABq, one of ArCH2), 7.48 – 7.53 (2H, m, 2 x Aromatic CH), 7.72 – 7.76 (1H, m, 
1 x Aromatic CH), 7.87 – 7.91 (3H, m, 3 x Aromatic CH), 8.30 (2H, d, J 7.8, 2 x Aromatic CH); δC (CDCl3, 100 MHz) 42.3 (CH2, ArCH2), 102.2 (Cq, 
Cspiro), 124.1 (CH, 2 x Aromatic CH), 126.0, 126.4 (CH, 2 x Aromatic CH), 128.9 (CH, 2 x Aromatic CH), 129.1 (CH, 1 x Aromatic CH), 131.2 (Cq, 
Aromatic Cq), 132.2 (Cq, Aromatic Cq), 133.4 (Cq, Aromatic Cq), 137.0 (CH, 1 x Aromatic CH), 149.1 (Cq, Aromatic Cq), 153.3 (Cq, C=N), 195.6 
(Cq, C=O). The more polar second fraction to elute was the kinetic isomer 20  (0.048 g, 24%); mp 168 -  170°C; νmax/cm-1 (neat) 1711, 1517; δH 
(400 MHz, CDCl3) 3.61 (1H, d, J 18.3, A of ABq, one of ArCH2), 3.88 (1H, d, J 18.3, B of ABq, one of ArCH2), 7.62 (2H, t, J 8.3, 2 x Aromatic CH), 7.67 
(2H, d, J 8.8, 2 x Aromatic CH2, 7.81 – 7.89 (1H, m, 1 x Aromatic CH), 7.97 (1H, d, J 7.6, 1 x Aromatic CH), 8.21 (2H, d, J 8.9, 2 x Aromatic CH); δC 
(CDCl3, 100 MHz) 31.5 (CH2, ArCH2), 92.5 (Cq, Cspiro), 124.4 (CH, 2 x Aromatic CH), 125.9, 127.2 (CH, 2 x Aromatic CH), 129.2 (CH, 2 x Aromatic 
CH), 129.8 (CH, 1 x Aromatic CH), 131.6, 136.2 (Cq, 2 x Aromatic Cq), 137.3 (CH, 1 x Aromatic CH),  148.8 (Cq, 1 x Aromatic Cq), 149.4 (Cq, 1 x 
Aromatic Cq), 157.5 (Cq, C=N), 190.4 (Cq, C=O). 
Representative procedure for reaction conditions for synthesis of the thermodynamic 1,2,5-oxathiazole-S-
oxide as major product 
* In general, flow reactions were conducted using a Vapourtec E-Series reactor (Vapourtec V3 peristaltic pumps), solution was pumped through 
a 10 mL reaction coil (Vapourtec part number 50-1011) heated to 100°C at a rate of 1 mL/min giving a residence time of 10 min, followed by a 
10 mm id Omnifit™ glass column (Vapourtec part number 30-3296) packed with Alumina (volume ~ 1 mL). PFA tubing was used throughout the 
system. The reaction mixture passed through a fixed 7 bar back pressure regulator (Kinesis part no. P-787), the crude material was collected as 
an orange solution and concentrated under reduced pressure. 
(2S,2'R)-4'-(4-nitrophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide 21 
The imidoyl chloride 67 (0.278 g, 1.38 mmol, 2.3 eq) was added portionwise over 10 min, at room temperature to a vigorously stirred solution 
of aqueous NaOH (1M, 10 mL) and dichloromethane (10 mL). After complete addition, the mixture was stirred for a further 10 min. The layers 
were separated, and the organic layer was dried with anhydrous MgSO4 and concentrated under reduced pressure. After concentration in vacuo 
the dipole 14 was isolated as a white solid and dissolved in ethyl acetate/dichloromethane  (1 : 1, 5 mL). The α-diazosulfoxide 1 (0.105 g, 0.51 
mmol, 1 eq) was dissolved in ethyl acetate/dichloromethane (1 : 1, 5 mL) and subsequently added to the solution of the dipole 14. Using a 
Vapourtec E-Series reactor (peristaltic pumps), this solution was pumped through a 10 mL reaction coil heated to 100°C at a rate of 1 mL/min 
giving a residence time of 10 min, followed by a 10 mm id Omnifit™ glass column packed with Alumina (volume ~ 1 mL).35 The reaction mixture 
passed through a 7 bar back pressure regulator (Kinesis part no. P-787), the crude material was collected as an orange solution and concentrated 
under reduced pressure to give the crude product as an orange crystalline solid (0.195 g). Analysis by 1H NMR spectroscopy showed the material 
to be a mixture of the thermodynamic (21) and kinetic (20) cycloadducts along with a regioisomer (22) and an unknown impurity (56 : 10 : 14 : 
30). The crude material was purified by trituration with ether and isolation of a crop of the thermodynamic isomer 21 was achieved as an off 
white crystalline solid (0.089 g, 52%). In some instances, the crude reaction mixture was dissolved in the minimum amount of dichloromethane, 
and purified by column chromatography on silica gel using gradient hexane-ethyl acetate as eluent (100 : 0 – 50 : 50). 
White crystalline solid (0.089 g, 52%) ; mp 159-161°C; νmax/cm-1 (neat) 1699, 1522, 1345; δH (400 MHz, CDCl3) 3.42 (1H, d, J 19.3, A of ABq, CH2), 
4.12 (1H, d, J 19.3, B of ABq, CH2), 7.52 (2H, d, J 8.9, 2 x ArH on ArNO2), 7.62 (2H, t, J 8.2, 7.2 2 x Aromatic CH), 7.84 (1H, t, J 7.4, 8.4,  1 x Aromatic 
CH), 7.99 (1H, d, J 7.7, 1 x Aromatic CH) 8.23 (2H, d, J 8.9, 2 x ArH on ArNO2);  δC (CDCl3, 100 MHz) 28.4 (CH2, ArCH2), 96.6 (Cq, Cspiro), 124.5 (CH, 
2 x Aromatic CH), 126.3, 127.1 (CH, 2 x Aromatic CH), 129.1  (CH, 2 x Aromatic CH), 129.6 (CH, Aromatic CH), 131.9, 134.0 (Cq, 2 x Aromatic Cq), 
137.5 (CH, 1 x Aromatic CH), 149.5, 151.2 (Cq, 2 x Aromatic Cq), 156.5 (Cq, C=N), 192.0 (Cq, C=O). HRMS (ESI+) Exact mass calculated for 
C16H11N2O5S [M+H]+, 343.0389. Found: 343.0388. The relative stereochemistry of the thermodynamic isomer 21 was established by single crystal 
X-ray diffraction on a crystal grown by slow recrystallization from dichloromethane and toluene over 4 - 5 weeks. Crystal data for 21: C16H10N2OS, 
Mr = 342.32 , triclinic  P-1, a =  7.5520(11) Å, b = 8.2283(11) Å, c = 12.8010(18) Å, a = 74.726 (4), β =86.674 (5)°, g = 72.819 (4) V = 732.95 (18) Å3, 
Z = 2, Dc = 1.55 g cm-3, F000 = 352, Mo Kα radiation, λ = 0.7107 Å, T = 300(2) K, 2θmax = 26.40°, μ = 0.252 mm-1, 15211 reflections collected, 2275 
unique (Rint = 0.0445), final GooF = 1.054, R1 = 0.0510, wR2 = 0.1583 (2275 obs. data: I > 2σ(I)); R1 = 0.0643, wR2 =  0.1729 (all data). 
(2S,2'R)-4'-Phenylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide 27 
White crystalline solid (0.089 g, 32%). Found C, 64.41; H 3.91; N 4.77. C16H11NO3S requires C, 64.63; H 3.73 ; N 4.71; mp 101-102°C; νmax/cm-1 
(neat) 1713, 1157; δH (400 MHz, CDCl3) 3.49 (1H, d, J 19.2, A of ABq, CH2), 4.07 (1H, d, J 19.2, B of ABq, CH2), 7.29 – 7.60 (7H, m, 7 x Aromatic CH), 
7.79 (1H, t, J 8.5, 1 x Aromatic CH), 7.96  (1H, d, J 7.8, 1 x Aromatic CH); δC (CDCl3, 100 MHz); 28.9 (CH2, ArCH2), 97.4 (Cq, Cspiro), 125.6 (Cq, 
Aromatic Cq), 126.1, 127.0 (2 x CH, 2 x Aromatic CH), 128.0 (CH, 2 x Aromatic CH), 129.2, (CH, 1 x Aromatic CH), 129.4 (CH, 2 x Aromatic CH), 
131.7 (CH, 1 x Aromatic CH), 134.3 (Cq, 1 x Aromatic Cq), 137.1 (CH, 1 x Aromatic CH), 151.6 (Cq, Aromatic Cq), 158.0 (Cq, C=N), 192.6 (Cq, C=O); 
HRMS (ESI+) Exact mass calculated for C16H10NO3S [M-H]+, 296.0381. Found: 296.0375. The relative stereochemistry of the cycloadduct  27 was 
determined by single crystal X-ray diffraction on a crystalline sample of  27 recrystallized from dichloromethane/hexane. Crystals of  27 are 
triclinic, space group P -1. Crystal data for C16H11NO3S, Mr = 297.32, a =  7.342 (2) Å, b = 8.954 (3) Å, c = 11.714 (3) Å, α = 70.226 (9)°, β = 83.607 
(9)°, γ = 72.230 (9), V = 960.1 (3) Å3, Z = 2, Dc = 1.431 g cm-3, F000 = 308, Mo Kα radiation, λ = 0.710 Å, T = 300 K, 2θmax = 1.000°, μ = .243 mm-1, 
6640 reflections collected, 2407 unique (Rint = 0.0360), final GooF = 1.055, R1 = 0.0405, wR2 = 0.1080 (1976 obs. data: I > 2σ(I)); R1 = 0.0503, wR2 
=  0.1166 (all data).  
(2S,2'R)-4'-(4-(tert-Butyl)phenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide 34 
The first fraction contained the thermodynamic isomer 34  (0.066 g, 30%); as a yellow crystalline solid; mp 119 – 120°C; νmax/cm-1 (neat) 2961, 
1712, 1267, 1149;  δH(400 MHz, CDCl3) 1.29 (9H, s, 3 x CH3), 3.54 (1H, d, J 19.4, A of ABq, one of ArCH2), 4.08 (1H, d, J 19.4, B of ABq, one of ArCH2), 
7.22 – 7.26 (2H, m, 2 x Aromatic CH), 7.35 – 7.37 (2H, m, 2 x Aromatic CH), 7.56 – 7.59 (2H, m, 2 x Aromatic CH), 7.79 (1H, t, J 8.5, 1 x Aromatic 
CH), 7.96 (1H, d, J 7.8, 1 x Aromatic CH); δC (CDCl3, 100 MHz); 29.0 (CH2, ArCH2), 31.0 (CH3, 3 x CH3), 35.0 [Cq, Cq(CH3)3],  97.5 (Cq, Cspiro), 122.6 
(Cq, Aromatic Cq), 126.1 (CH, 1 x Aromatic CH), 126.4 (CH, 2 x Aromatic CH), 127.0 (CH, 1 x Aromatic CH), 127.8 (CH, 2 x Aromatic CH), 129.1 (CH, 
1 x Aromatic CH), 134.3 (Cq, Aromatic Cq), 137.0 (CH, Aromatic CH), 151.7 (Cq, Aromatic Cq), 155.4 (Cq, Aromatic Cq), 157.8 (Cq, C=N), 192.7 
(Cq, C=O); HRMS (ESI+) Exact mass calculated for C20H20NO3S [M+H]+, 354.1164. Found: 354.1169. The relative stereochemistry of the 
cycloadduct 34 was determined by single crystal X-ray diffraction on a crystalline sample of 34 recrystallized from dichloromethane/hexane. 
Crystals of 34 are monoclinic, space group P 21/c. Crystal data for C20H19NO3S, Mr = 353.42, a =  11 .0131 (2) Å, b = 11.9246 (2) Å, c = 14.5681 (3) 
Å, α = γ = 90 °C, β = 107.106 (10)°, V = 1828.55 (6) Å3, Z = 4, Dc = 1.284 g cm-3, F000 = 744, Cu Kα radiation, λ = 1.541 Å, T = 296 K, 2θmax = 0.750°, 
μ = 1.721 mm-1, 22017 reflections collected, 3172 unique (Rint = 0.0256), final GooF = 1.060, R1 = 0.0549, wR2 = 0.1588, (3041 obs. data: I > 2σ(I)); 
R1 = 0.0562, wR2 =  0.1600 (all data). The second fraction to elute contained the 1,4,2-oxathiazole-S-oxide regioisomer 40 (0.011 g, 5%) Yellow 
oil. νmax/cm-1 (neat) 2962, 1726, 1272, 1083; δH (400 MHz, CDCl3) 1.33 (9H, s, 3 x CH3), 3.31 (1H, d, J 17.3, A of ABq, one of ArCH2), 3.47 (1H, d, J 
17.3, B of ABq, one of ArCH2), 7.74 – 7.57 (4H, m, 4 x Aromatic CH), 7.76 (1H, t, J 7.8,  1 x Aromatic CH), 7.87 (2H, d, J 7.8, 2 x Aromatic CH), 7.97 
(1H, d, J 7.8, 1 x Aromatic CH); δC (CDCl3, 100 MHz); 31.0 (CH3, 3 x CH3), 33.6 (CH2, ArCH2), 35.2 [Cq, Cq(CH3)3], 107.9 (Cq, Cspiro), 122.1 (Cq, 
Aromatic Cq), 125.5 (CH, 1 x Aromatic CH), 126.7 (CH, 2 x Aromatic CH), 127.1, (CH, 1 x Aromatic CH), 128.8 (CH, 2 x Aromatic CH), 129.3 (CH, 1 
x Aromatic CH), 135.3 (Cq, 1 x Aromatic Cq), 137.0 (CH, 1 x Aromatic CH), 147.5 (Cq, 1 x Aromatic Cq), 156.0 (Cq, 1 x Aromatic Cq), 159.4 (Cq, 
C=N), 189.2 (Cq, C=O); HRMS (ESI+) Exact mass calculated for C20H20NO3S [M+H]+, 354.1164. Found: 354.1175. 
(2S,2'R)-4'-(4-Fluorophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide  31 
The first fraction contained the thermodynamic isomer 31 (0.070, 35%) as a yellow crystalline solid; Found C, 60.45; H 3.30 N 4.73. C16H10NFO3S 
requires C, 60.95; H 3.20 ; N 4.44;  mp 107 - 109°C; νmax/cm-1 (neat) 3073, 1715, 1154; δH (400 MHz, CDCl3) 3.45 (1H, d, J 19.2, A of ABq, one of 
ArCH2), 4.08 (1H, d, J 19.2, B of ABq, one of ArCH2), 7.05 (2H, t, J 8.6, 2 x Aromatic CH), 7.29 – 7.33 (2H, m, 2 x Aromatic CH), 7.59 (2H, t, J  8.5, 2 
x Aromatic CH), 7.80 (1H, t, J 8.9,  1 x Aromatic CH), 7.98  (1H, d, J 7.5, 1 x Aromatic CH);  δC (CDCl3, 100 MHz) 28.8 (CH2, ArCH2), 97.2 (Cq, Cspiro), 
116.8 (CH, 2 x Aromatic CH, d, 2JCF  22),  121.8 (Cq, d, 4JCF 3.6, 1 x Aromatic Cq), 126.2, 127.1, 129.3 (CH, 3 x Aromatic CH), 130.2 (CH, 2 x ArCH, d, 
3JCF 8), 134.1 (Cq, 1 x Aromatic Cq), 137.3 (CH, 1 x Aromatic CH), 151.5 (Cq, 1 x Aromatic Cq), 157.0 (Cq, C=N), 164.7 (Cq, 1 x Aromatic CF, d, 1JCF 
257), 192.5 (Cq, C=O). (M+H)+ 316 (10%); HRMS (ESI+) Exact mass calculated for C16H11NO3FS [M+H]+, 316.0444. Found: 316.0447. The second 
fraction contained the kinetic isomer 32 (0.023 g, 12%) Yellow oily residue; νmax/cm-1 (neat) 1716, 1602, 1510, 1160; δH (400 MHz, CDCl3) 3.60 
(1H, d, J 18.5, A of ABq, one of ArCH2), 3.83 (1H, d, J 18.0, B of ABq, one of ArCH2), 7.04 (2H, t, J 8.6, 2 x Aromatic CH), 7.46 – 7.50 (2H, m, 2 x 
Aromatic CH), 7.58 – 7.65 (2H, m, 2 x Aromatic CH), 7.82 (1H, t, J 8.2, 1 x Aromatic CH), 7.96 (1H, d, J 7.7, 1 x Aromatic CH);  δC (CDCl3, 100 MHz) 
31.8 (CH2, ArCH2), 93.2 (Cq, Cspiro), 116.7 (CH, 2 x Aromatic CH, d, 2JCF  21),  121.6 (Cq, d, 4JCF 3.6, 1 x Aromatic Cq), 125.7, 127.1, 129.5 (CH, 3 x 
Aromatic CH), 130.4 (CH, 2 x Aromatic CH, d, 3JCF 8.6), 136.4 (Cq, 1 x Aromatic Cq), 136.9 (CH, 1 x Aromatic CH), 149.0 (Cq, 1 x Aromatic Cq), 158.0 
(Cq, C=N), 164.7 (Cq, 1 x Aromatic CF, d, 1JCF 255), 190.7 (Cq, C=O); MS: (M+H)+ 316 (10%); HRMS (ESI+) Exact mass calculated for C16H11NO3FS 
[M+H]+, 316.0444. Found: 316.0444. The third fraction to elute was the 1,4,2-oxathiazole-S-oxide regiosiomer 33 as a yellow crystalline solid 
(0.08 g, 4%); νmax/cm-1 (neat) 1725, 1601, 1238. 1082; δH (400 MHz, CDCl3) 3.33 (1H, d, J 17.0, A of ABq, one of ArCH2), 3.51 (1H, d, J 17.2, B of 
ABq, one of ArCH2), 7.19 – 7.24 (3H, m, 3 x Aromatic CH), 7.51 – 7.58 (2H, m, 2 x Aromatic CH), 7.78 (2H, t, J 8.5, 2 x Aromatic CH), 7.93 – 7.98 
(2H, m, 2 x Aromatic CH); δC (CDCl3, 100 MHz)*; 33.6 (CH2, ArCH2), 108.4 (Cq, Cspiro), 117.1 (CH, d, 2JCF  21, 2 x Aromatic CH),  125.6, 127.1 129.4 
(CH, 3 x Aromatic CH), 131.0 (CH, d, 3JCF 9.2, 2 x Aromatic CH), 137.2 (CH, 1 x Aromatic CH), 147.4 (Cq, 1 x Aromatic Cq); MS: (M+H) 316 (15%); 
HRMS (ESI+) Exact mass calculated for C16H11NO3FS [M+H]+, 316.0444. Found: 316.0454. Note:*The C=O, C-F, one Aromatic Cq, and the C=N 
signal were not detected in the 13C NMR spectrum. 
(2S,2'R)-4'-(2,5-Difluorophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one 2'-oxide 37  
Careful and repeated chromatography was required for isolation of the thermodynamic isomer as a yellow oily residue (0.026 g, 11%).  νmax/cm-
1 (neat) 1720, 1162, 1429;  δH (400 MHz, CDCl3) 3.37 (1H, d, J 18.8, A of ABq, one of ArCH2), 3.99 (1H, d, J 18.8, B of ABq, one of ArCH2), 6.99 – 7.04 
(1H, complex m, 1 x Aromatic CH), 7.18 – 7.23 (1H, m, 1 x Aromatic CH), 7.76 (3H, t, J  8.9, 2 x Aromatic CH), 7.74 (1H, t, J 8.7, 1 x Aromatic CH), 
7.92 (1H, d, J 7.6, 1 x Aromatic CH);  δC (CDCl3, 100 MHz) 28.3 (CH2, ArCH2), 97.1 (Cq, Cspiro), 115.3 (CH, dd, 2JCF 15.7, 3JCF  8.9, Aromatic C-3), 117.8 
(CH, dd, 2JCF 24.7, 3JCF  8.5, Aromatic C-6), 118.1 (CH, dd, 2JCF 26.3, 3JCF  3.3, Aromatic C-4), 120.6 (CH, dd, 2JCF 24.1, 3JCF  9.1, Aromatic C-1), 125.9. 
126.6, 128.9 (CH, 3 x Aromatic CH), 134.1 (Cq, 1 x Aromatic Cq), 136.5 (CH, 1 x Aromatic CH),  151.1 (Cq, 2 x Aromatic Cq), 154.4 (Cq, C=N), 156.3 
(Cq, dd, 1JCF 251.3, 4JCF 5.9, 1 x C-F), 158.7 (Cq, d, 1JCF 244.8, 1 x C-F),  191.1 (Cq, d, 5JCF 4.2, C=O); MS (M+) 333 (15%); HRMS (ESI+) Exact mass 
calculated for C16H10NO3F2S [M+H]+, 334.0360 Found: 334.0349.  
4-Methyl-4'-phenylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 42 
White crystalline solid (0.089 g, 30%). The first fraction contained the 1,2,5-oxathiazole-S-oxide thermodynamic isomer 42; m.p. 150 – 151°C; 
νmax/cm-1 (neat) 1709, 1156, 762; δH (400 MHz, CDCl3) 2.38 (3H, s, CH3),  3.32 (1H, d, J 19.0, A of ABq, one of ArCH2), 3.98 (1H, d, J 19.2, B of ABq, 
one of ArCH2), 7.29 – 7.31 (2H, m, 2 x Aromatic CH), 7.36 (2H, t, J 8.4, 2 x Aromatic CH), 7.46 – 7.51 (2H, m, 2 x Aromatic CH), 7.59 (1H, d, J 7.3, 1 
x Aromatic CH), 7.80 (1H, d, J 7.6, 1 x Aromatic CH); δC (CDCl3, 100 MHz) 17.8 (CH3, ArCH3), 27.9 (CH2, ArCH2), 97.4 (Cq, Cspiro), 123.5 (CH, 1 x 
Aromatic CH), 125.7 (Cq, 1 x Aromatic Cq), 127.9 (CH, 2 x Aromatic CH), 129.3 (CH, 1 x Aromatic CH), 129.4 (CH, 2 x Aromatic CH), 131.7 (CH, 1 x 
Aromatic CH), 134.1 (Cq, 1 x Aromatic Cq), 136.6 (Cq, 1 x Aromatic Cq), 137.7 (CH, 1 x Aromatic CH),  150.5 (Cq, 1 x Aromatic Cq), 158.0 (Cq, C=N), 
192.8 (Cq, C=O); (M)+ 311 (5%); HRMS (ESI+) Exact mass calculated for C17H14NO3S [M+H]+, 312.0694. Found: 312.0687. 
4'-(4-Fluorophenyl)-4-methylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 45  
The first fraction isolated contained the thermodynamic isomer 45 as a white crystalline solid (0.098 g, 45%); mp 147 - 149°C, νmax/cm-1 (neat) 
1714, 1232, 1154;  δH (400 MHz, CDCl3) 2.39 (3H, s, CH3), 3.28 (1H, d, J 19.2, A of ABq, one of CH2), 3.98 (1H, d, J 19.2, B of ABq, one of CH2), 7.06 
(2H, t, J 8.6, 2 x Aromatic CH), 7.29 – 7.33 (2H, m, 2 x Aromatic CH), 7.50 (1H, t, J 7.8, 1 x Aromatic CH), 7.60 (1H, d, J 7.3, 1 x Aromatic CH), 7.80 
(1H, d, J 7.7, 1 x Aromatic CH);  δC (CDCl3, 100 MHz) 17.8 (CH3, ArCH3), 27.8 (CH2, ArCH2), 97.1 (Cq, Cspiro), 116.8 (CH, d, 2JCF  22, 2 x Aromatic CH),  
121.9 (d, 4JCF 3.6, 1 x ArCq), 123.5 (CH, 1 x Aromatic CH), 129.4 (CH, 1 x Aromatic CH), 130.2 (1 signal representing 2 x ArCH, d, 3JCF 8), 134.0 (Cq, 
1 x Aromatic Cq), 136.7 (Cq, 1 x Aromatic Cq), 137.8 (CH, 1 x Aromatic CH), 150.4 (Cq, 1 x Aromatic Cq), 157.0 (Cq, C=N), 164.6 (Cq, 1 x Aromatic 
CF, d, 1JCF 255), 192.8 (Cq, C=O); HRMS (ESI+) Exact mass calculated for C17H13NO3FS [M+H]+, 330.0600. Found: 330.0588.The relative 
stereochemistry of the cycloadduct 45 was determined by single crystal X-ray diffraction on a crystalline sample of 45 recrystallized from 
dichloromethane/hexane. Crystals of 45 are orthorhombic, space group Pbca. α=β=γ= 90°C, Crystal data for C17H12NFO3S Mr = 329.34, a =  15.237 
(3) Å, b = 11.212 (2) Å, c = 17.948 (3) Å, β = 90 (2)°, V = 3066.2 (10) Å3, Z = 8, Dc = 1.427 g cm-3, F000 = 1360, Mo Kα radiation, λ = 0.71073 Å, T = 
296 K, 2θmax = 67.14°, μ = 2.111 mm-1, 16848 reflections collected, 2637 unique (Rint = 0.0398), final GooF = 1.097, R1 = 0.0448, wR2 = 0.1302, 
(2617 obs. data: I > 2σ(I)); R1 = 0.0448, wR2 =  0.1303 (all data). A second fraction isolated from the column contained the 1,4,2-oxathiazole-S-
oxide Regioisomer 47 (0.026 g, 12%) Yellow crystalline solid; νmax/cm-1 (neat) 1724, 1600, 1238, 1080; δH (400 MHz, CDCl3); 2.35 (3H, s, CH3), 3.15 
(1H, d, J 17.4, A of ABq, one of CH2), 3.41 (1H, d, J 17.4, B of ABq, one of CH2), 7.22 (2H, t, J 8.4, 2 x Aromatic CH), 7.47 (2H, t, J 8.8, 2 x Aromatic 
CH), 7.58 (1H, d, J 7.2,  2 x Aromatic CH), 7.82 (1H, d, J 7.4, 1 x Aromatic CH), 7.94 – 7.97 (2H, m, 2 x Aromatic CH);  δC (CDCl3, 100 MHz); 17.8 
(CH3, ArCH3), 32.4 (CH2, ArCH2), 108.2 (Cq, Cspiro), 117.0 (CH, 2 x Aromatic CH, d, 2JCF  23.6), 121.5 (Cq, 1 x Aromatic Cq),  122.9, 129.5 (2 x CH, 2 x 
Aromatic CH), 131.0 (CH, 2 x Aromatic CH, d, 3JCF 8.8), 135.1, 136.4 (Cq, 2 x Aromatic Cq), 137.7 (CH, 1 x Aromatic CH), 146.5 (Cq, 1 x Aromatic 
Cq), 158.4 (Cq, C=N), 164.8 (Cq, 1 x Aromatic CF, d, 1JCF 256), 189.3 (Cq, C=O); ESI+ (M+H)+ 330 (10%); HRMS (ESI+) Exact mass calculated for 
C17H13NO3FS [M+H]+, 330.0600 Found: 330.0594.  
4'-(4-(tert-Butyl)phenyl)-4-methylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 48 
White crystalline solid (0.041 g, 26%). mp 105 - 106°C; νmax/cm-1 (neat) 1721, 1269, 1173; δH (400 MHz, CDCl3) 1.28 (9H, s, 3 x CH3), 2.37 (3H, s, 
ArCH3), 3.38 (1H, d, J 19.2, A of ABq, one of CH2), 3.98 (1H, d, J 19.2, B of ABq, one of CH2), 7.25 (2H, d, J 7.9, 2 x Aromatic CH), 7.37 (2H, d, J 8.5, 
2 x Aromatic CH), 7.48 (1H, t, J 7.8, 1 x Aromatic CH), 7.59 (1H, d, J 7.3, 1 x Aromatic CH), 7.79 (1H, d, J 7.6, 1 x Aromatic CH);  δC (CDCl3, 100 MHz) 
17.9 (CH3, ArCH3), 28.0 (CH2, ArCH2), 31.0 (CH3, 1 signal representing 3 x CH3), 35.0 [Cq, Cq(CH3)3],  97.4 (Cq, Cspiro), 122.7 (Cq, Aromatic Cq),  123.4 
(CH, 1 x Aromatic CH), 126.4, 127.7 (CH, 2 signals representing 4 x Aromatic CH),  129.3 (CH, 1 x Aromatic CH),  134.1 (Cq, 1 x Aromatic Cq), 136.6 
(Cq, 1 x Aromatic Cq), 137.6 (CH, 1 x Aromatic CH), 150.5, 155.4 (2 x Cq, 2 x Aromatic Cq), 157.8 (Cq, C=N), 193.0 (Cq, C=O); HRMS (ESI+) Exact 
mass calculated for C21H22NO3S [M+H]+, 368.1320. Found: 368.1326. 
4-Methyl-4'-(4-nitrophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 51 
White crystalline solid. (0.049 g, 20%). mp 139 – 141°C; νmax/cm-1 (neat) 1716, 1521, 1346, 1151; δH (400 MHz, CDCl3); 2.32 (3H, s, ArCH3), 3.25 
(1H, d, J 19.2, A of ABq, one of CH2), 4.01 (1H, d, J 19.2, B of ABq, one of CH2), 7.50 – 7.54 [3H, m overlapping 2H doublet (2 x Aromatic CH) and 
1H, m (1 x Aromatic CH)], 7.63 (1H, d, J 7.5, 1 x Aromatic CH), 7.82 (1H, d, J 7.5, 1 x Aromatic CH), 8.23 (2H, d, J 8.8, 2 x Aromatic CH); δC (CDCl3, 
100 MHz) 17.9 (CH3, ArCH3), 27.5 (CH2, ArCH2), 96.5 (Cq, Cspiro), 123.7 (CH, 1 x Aromatic CH), 124.5 (CH, 2 x Aromatic CH), 129.0 (CH, 2 x Aromatic 
CH), 129.7 (CH, 1 x Aromatic CH), 132.0, 133.8, 136.8 (3 x Cq, 3 x Aromatic Cq), 138.1 (CH, 1 x Aromatic CH), 149.5 (Cq, 1 x Aromatic Cq), 150.1 
(Cq, 1 x Aromatic Cq), 156.6 (Cq, C=N), 192.3 (Cq, C=O); HRMS (ESI+) Exact mass calculated for C17H13N2O5S [M+H]+, 357.0545 Found: 357.0531. 
6-Methyl-4'-phenylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 54 
Thermodynamic isomer 54 was isolated as a pale yellow solid (0.053g, 34%); Found C, 65.80; H 4.34; N 4.50. C17H13NO3S requires C, 65.58; H 
4.21; N 4.50; m.p. 147-149 °C; νmax/cm-1 (neat) 1712, 1276, 1153; δH (300 MHz, CDCl3) 2.49 (3H, s, CH3), 3.42 (1H, d, J 19.2, A of ABq, one of 
ArCH2), 4.02 (1H, d, J 19.2, B of ABq, one of ArCH2), 7.28 – 7.37 (4H, m, 4 x Aromatic CH), 7.45 – 7.47 (2H, m, 2 x Aromatic CH), 7.59 (2H, dd, J 7.7, 
1.2, 1 x Aromatic CH), 7.75 (1H, br s, 1 x Aromatic CH); δC (CDCl3, 75.5MHz) 21.1 (CH3, ArCH3), 28.5 (CH2, ArCH2), 97.7 (Cq, Cspiro), 125.7 (Cq, 
Aromatic Cq), 125.8 (CH, 1 x Aromatic CH), 126.6 (CH, 1 x Aromatic CH), 128.0, 129.3 (2 x CH, 4 x Aromatic CH), 131.6 (CH, 1 x Aromatic CH), 
134.4 (Cq, 1 x Aromatic Cq), 138.4 (CH, 1 x Aromatic CH), 139.5 (Cq, 1 x Aromatic Cq), 149.0 (Cq, 1 x Aromatic Cq), 158.0 (Cq, C=N), 192.6 (Cq, 
C=O); m/z (ESI+) 312 (30%); HRMS (ESI+) Exact mass calculated for C17H14NO3S [M+H]+, 312.0694 Found: 312.0683. The second fraction to elute 
was the 1,4,2-oxathiazole-S-oxide Regioisomer 56 (0.039 g, 25%) as a white crystalline solid; m.p. 152-154°C (decomp);  νmax/cm-1 (neat) 1726, 
1492, 1282, 1084;  δH (300 MHz, CDCl3) 2.47 (3H, s, CH3), 3.26 (1H, d, J 17.3, A of ABq, one of ArCH2), 3.45 (1H, d, J 17.3, B of ABq, one of ArCH2), 
7.38 (1H, d, J 7.9, 1 x Aromatic CH), 7.48 – 7.59 (4H, m, 4 x Aromatic CH), 7.76 (1H, br s, 1 x Aromatic CH), 7.92 – 7.95 (2H, d, J 7.8, 2 x Aromatic 
CH); δC (CDCl3, 75.5 MHz); 21.2 (CH3, ArCH3), 33.3 (CH2, ArCH2), 108.5 (Cq, Cspiro), 125.2 (Cq, 1 x Aromatic Cq), 125.4, 126.7, 128.8, 129.6, 132.1 
(5 signals representing 7 x Aromatic CH), 135.4 (Cq, 1 x Aromatic Cq), 138.3 (CH, 1 x Aromatic CH), 139.7 (Cq, 1 x Aromatic Cq), 144.8 (Cq, 1 x 
Aromatic Cq), 159.4 (Cq, C=N), 189.0 (Cq, C=O); MS (ESI+) 312 (20%); HRMS (ESI+) Exact mass calculated for C17H14NO3S [M+H]+, 312.0694. Found: 
312.0704. 
4'-(4-Fluorophenyl)-6-methylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 57   
The thermodynamic isomer 57 (0.032 g, 36%) was isolated as a white crystalline solid; Found C, 61.61; H 3.79; N 4.37. C17H12NFO3S requires C, 
62.00; H 3.67; N 4.25; m.p. 156-158 °C  νmax/cm-1 (neat) 1711, 1162, 806; δH (300 MHz, CDCl3); 2.49 (3H, s, CH3), 3.40 (1H, d, J 19.7, A of ABq, one 
of ArCH2), 4.03 (1H, d, J 19.7, B of ABq, one of ArCH2), 7.05 (2H, t, J 8.9, 2 x Aromatic CH), 7.28 – 7.34 (2H, m, 2 x Aromatic CH), 7.46 (1H, d, J 8.0, 
1 x Aromatic CH), 7.61 (1H, d, J 7.9, 1 x Aromatic CH), 7.74 (1H, br s, 1 x Aromatic CH); δC (CDCl3, 100 MHz); 21.1 (CH3, ArCH3), 28.4 (CH2, ArCH2), 
97.5 (Cq, Cspiro), 116.7 (CH, 1 signal representing 2 x Aromatic CH, d, 2JCF 22.2), 121.9 (Cq, 1 x Aromatic Cq, d, 4JCF 3.3),  125.9 (CH, 1 x Aromatic 
CH), 126.7 (CH, 1 x Aromatic CH), 130.2 (CH, 2 x ortho Aromatic CH, d, 3JCF 8.7),  134.4, (Cq, 1 x Aromatic Cq), 138.5 (CH, 1 x Aromatic CH), 139.6 
(Cq, 1 x Aromatic Cq), 148.9 (Cq, Aromatic Cq), 157.0 (Cq, C=N), 164.6 (Cq, 1 x Aromatic CF, d, 1JCF  254.4), 192.5 (Cq, C=O); MS (M)+ 330 (60%); 
HRMS (ESI+) Exact mass calculated for C17H13FNO3S [M+H]+, 330.0600 Found: 330.0600. The second fraction to elute isolated contained the 
kinetic 1,2,5-oxathiazole-S-oxide 58 (0.004 g, 5%), δH (400 MHz, CDCl3) 2.49 (3H, s, CH3), 3.53 (1H, d, J 18.5, A of ABq, one of ArCH2), 3.77 (1H, d, 
J 18.5, B of ABq, one of ArCH2), 7.03 (2H, t, J 8.9, 2 x Aromatic CH), 7.45– 7.51 (3H, m, 3 x Aromatic CH), 7.58 – 7.63 (1H, m, 1 x Aromatic CH), 7.75 
(1H, br s, 1 x Aromatic CH); (M+H)+ 330 (25%), HRMS (ESI+) Exact mass calculated for C17H13NO3FS [M+H]+, 330.0600. Found: 330.0605. The third, 
most polar fraction to elute contained the 1,4,2-oxathiazole-S-oxide regioisomer 59 (0.008 g, 10%) as a colorless oil; νmax/cm-1 (neat) 1722, 1282, 
1157, 1083; δH (600 MHz, CDCl3) 2.47 (3H, s, CH3), 3.26 (1H, d, J 17.3, A of ABq, one of ArCH2), 3.45 (1H, d, J 17.3, B of ABq, one of ArCH2), 7.22 
(2H, t, J 8.4, 2 x Aromatic CH), 7.39 (1H, d, J 7.7, 1 x Aromatic CH), 7.56 – 7.60 (1H, d, J 8.3, 1 x Aromatic CH), 7.76 (1H, s, 1 x Aromatic CH), 7.92 
– 7.97 (2H, m, 2 x Aromatic CH); δC (CDCl3, 125 MHz) 21.2 (CH3, ArCH3), 33.3 (CH2, ArCH2), 108.7 (Cq, Cspiro), 117.0 (CH, 2 x ArCH, d, 2JCF 22.6), 
121.4 (Cq, d, 4JCF 3.3, 1 x Aromatic Cq), 125.4, 126.7 (CH, 2 x Aromatic CH), 131.0 (CH, 2 x Aromatic CH, d,  3JCF 9.4),  135.3 (Cq, 1 x Aromatic Cq), 
138.4 (CH, 1 x Aromatic CH), 139.8, 144.7 (2 x Cq, 2 x Aromatic Cq), 158.4 (Cq, C=N), 164.9 (Cq, 1 x Aromatic CF, d, 1JCF 254), 188.9 (Cq, C=O); MS 
(M)+ 329 (100%); HRMS (ESI+) Exact mass calculated for C17H12FNO3SNa [M+Na]+, 352.0420 Found: 352.0425. 
6-Methyl-4'-(4-nitrophenyl)spiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 62   
Thermodynamic isomer 62 was isolated as a white crystalline solid (0.100 g, 45%). Found C, 56.95; H 3.49; N 7.75. C17H12N2O5S requires C, 57.30; 
H 3.39 ; N 7.86; m.p. 128 – 130°C;  νmax/cm-1 (neat) 1707, 1523 1345, 1154; δH (300 MHz, CDCl3) 2.50 (3H, s, CH3), 3.35 (1H, d, J 19.4, A of ABq, 
one of ArCH2), 4.07 (1H, d, J 19.4, B of ABq, one of ArCH2), 7.47 – 7.53 [3H, 2 overlapping signals; (1H, d, J 8.5) and (2H, d, J 9.1, 2 x Aromatic CH)], 
7.63 (1H, d, J 8.1, 1 x Aromatic CH), 7.77 (1H, br s, 1 x Aromatic CH), 8.22 (2H, d, J 9.0, 2 x Aromatic CH); δC (CDCl3, 75 MHz) 21.2 (CH3, ArCH3), 
28.1 (CH2, ArCH2), 96.8 (Cq, Cspiro), 124.5 (CH, 2 x Aromatic CH), 126.1 (CH, 1 x Aromatic CH), 126.8 (CH, 1 x Aromatic CH), 129.0 (CH, 2 x Aromatic 
CH), 132.0, 134.2 (Cq, 2 x Aromatic Cq), 138.8 (CH, 1 x Aromatic CH), 140.0, 148.6, 149.5 (Cq, 3 x Aromatic Cq), 156.0 (Cq, C=N) 192.0 (Cq, C=O); 
HRMS (ESI+) Exact mass calculated for C17H13N2O5S [M+H]+, 357.0545. Found: 357.0549. A second fraction contained the kinetic 1,2,5-
oxathiazole-S-oxide diastereomer 63 (0.027 g, 11%); νmax/cm-1 (neat)  1714, 1522, 1347; δH (300 MHz, CDCl3) 2.51 (3H, s, CH3), 3.54 (1H, d, J 18.0,  
A of ABq, one of ArCH2), 3.82 (1H, d, J 18.0, B of ABq, one of ArCH2), 7.49 – 7.54 (1H, m, 1 x Aromatic CH), 7.61 – 7.72 [3H, 2 overlapping signals 
(1H, m, 1 x Aromatic CH) and (2H, d, J  9.0, 2 x Aromatic CH)], 7.75 (1H, br s, 1 x Aromatic CH), 8.20 (2H, d, J 9.0, 2 x Aromatic CH); δC (CDCl3, 75 
MHz) 21.2 (CH3, ArCH3), 31.3 (CH2, ArCH2), 92.8 (Cq, Cspiro), 124.21 (Cq, 1 x Aromatic Cq), 124.3 (CH, 2 x Aromatic CH), 125.6 (CH, 1 x Aromatic 
CH), 126.8 (CH, 1 x Aromatic CH), 129.1 (CH, 2 x Aromatic CH), 131.7 (Cq, 1 x Aromatic Cq), 136.5 (Cq, 1 x Aromatic Cq), 138.5 (CH, 1 x Aromatic 
CH), 140.3, 146.2 (Cq, 2 x Aromatic Cq), 157.6 (Cq, C=N), 190.3 (Cq, C=O); HRMS (ESI+) Exact mass calculated for C17H13N2O3S [M+H]+, 357.0545. 
Found: 357.0540. 
4'-(4-(tert-Butyl)phenyl)-6-methylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 60 
60 was isolated as a yellow oil (0.030 g, 15%). νmax/cm-1 (neat) 2963, 1714, 1156, 814; δH (300 MHz, CDCl3); 1.27 (9H, s, 3 x CH3), 2.49 (3H, s, 
ArCH3), 3.47 (1H, d, J 19.0, A of ABq, one of ArCH2), 4.03 (1H, d, J 19.0, B of ABq, one of ArCH2), 7.24 (2H, d, J 8.5, 2 x Aromatic CH), 7.36 (2H, d, J 
8.6, 2 x Aromatic CH), 7.45 (1H, d, J 7.9, 1 x Aromatic CH), 7.59 (1H, d, J 7.8, 1 x Aromatic CH), 7.74 (1H, br s, 1 x Aromatic CH);  δC (CDCl3, 75.5 
MHz) 21.1 (CH3, ArCH3) 28.7 (CH2, ArCH2), 31.0 (CH3, 1 signal representing 3 x CH3), 35.0 [Cq, C(CH3)3], 97.8 (Cq, Cspiro), 122.7 (Cq, Aromatic Cq), 
125.8 (CH, 1 x Aromatic CH), 126.4 (CH, 2 x Aromatic CH), 126.6 (CH, 1 x Aromatic CH), 127.8 (CH, 2 x Aromatic CH), 134.6 (Cq, 1 x Aromatic Cq), 
138.3 (CH, 1 x Aromatic CH), 139.4, 149.1, 155.3 (3 x Cq, 3 x Aromatic Cq), 157.8 (Cq, C=N), 192.7 (Cq, C=O); (M+H) 368 (60%); HRMS (ESI+) Exact 
mass calculated for C21H22NO3S [M+H]+, 368.1320. Found: 368.1306. 
4'-(2,5-Difluorophenyl)-6-methylspiro[indene-2,3'-[1,2,5]oxathiazol]-1(3H)-one S-oxide 65 
The thermodynamic isomer 65 was isolated as the major component of one fraction as a brown oil (~90% pure, 0.026 g, 16%). νmax/cm-1 (neat) 
1720, 1490, 1429, 1163; δH (300 MHz, CDCl3) 2.46 (3H, s, ArCH3), 3.31 (1H, d, J 18.8, A of ABq, one of ArCH2), 3.94 (1H, d, J 18.6, B of ABq, one of 
ArCH2), 7.01 (1H, t of d, J 9.4, 4.3, 1 x Aromatic CH), 7.13 – 7.22 (1H, m, 1 x Aromatic CH), 7.39 (1H, d, J 7.9, 1 x Aromatic CH), 7.46 – 7.51 (1H, m, 
1 x Aromatic CH), 7.55 (1H, d, J 7.5, 1 x Aromatic CH), 7.71 (1H, br s, 1 x Aromatic CH).  Characteristic signals of 65 identified in the 13C NMR 
spectrum include; δC (CDCl3, 75.5 MHz); 21.1 (CH3, ArCH3) 27.9 (CH2, ArCH2), 97.5 (Cq, Cspiro), 117.5 – 118.3 (2 overlapping dd corresponding to 2 
x Aromatic CH, including 1d 3JCF 8.8, 1d 4JCF 3.3), 120.5 (CH, 1 x Aromatic CH, dd, 2JCF 25,3JCF 9.3), 125.8 (CH, 1 x Aromatic CH), 126.3 (CH, 1 x 
Aromatic CH), 137.8 (CH, 1 x Aromatic CH), 148.5 (Cq, C=N), 156.2 (Cq, 1 x Aromatic CF, d, 1JCF 260),  158.6 (Cq, 1 x Aromatic CF, d, 1JCF 246),  191.1 
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